CompuMed (CMPD) Stock Price, News & Analysis

Company Overview

CompuMed, Inc., an enterprise telemedicine solutions company, provides clinical care services for patients and medical facilities. It offers telecardiology and teleradiology services that provide real-time access to U.S. Board-Certified specialists through cloud-based technology and integrated medical devices to medical facilities worldwide. The company also provides enterprise telemedicine solutions; a suite of telecardiology services and diagnostic exam interpretations for pediatric and adult patients, including electrocardiogram (ECG) devices, echocardiogram, ECG, vascular, holter, nuclear, and video consults; and reading, transcription, reporting, storage, and video consultations in the areas of Vscan, X-ray, ultrasound, mammography, computed tomography, magnetic resonance imaging, and radiologist video consults. It also offers OsteoGram software that works in combination with standard or digital X-ray equipment to support osteoporosis screening, diagnosis, and therapy monitoring. In addition, the company provides mobile ECG and ultrasound solutions that provide patients with immediate access to its board-certified specialists; and medical devices. It serves organ procurement organizations, rural healthcare, and correctional healthcare industries. CompuMed, Inc. was founded in 1973 and is headquartered in Los Angeles, California.

Key Stats

• Today's Range: $3.00 to $3.50
• 50-Day Range: $2.90 to $3.80
• 52-Week Range: $1.70 to $4.70
• Volume: 4,810 shs
• Average Volume: 2,068 shs
• Market Capitalization: $4.64 million
• P/E Ratio: 20.59
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CompuMed Stock Analysis - MarketRank™

CompuMed scored higher than 8% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for CompuMed.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of CompuMed is 20.59, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 22.58.

Price to Earnings Ratio vs. Sector

The P/E ratio of CompuMed is 20.59, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 26.74.

Price to Book Value per Share Ratio

CompuMed has a P/B Ratio of 1.45. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

0.48% of the float of CompuMed has been sold short.

Short Interest Ratio / Days to Cover

CompuMed has a short interest ratio ("days to cover") of 12.5, which indicates bearish sentiment.

Change versus previous month

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

CompuMed does not currently pay a dividend.

Dividend Growth

CompuMed does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.48% of the float of CompuMed has been sold short.

Short Interest Ratio / Days to Cover

CompuMed has a short interest ratio ("days to cover") of 12.5, which indicates bearish sentiment.

Change versus previous month

News and Social Media

• Score: 1.2 / 5
• News Sentiment: N/A

News Sentiment

CompuMed has a news sentiment score of -0.88. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.82 average news sentiment score of Medical companies.

MarketBeat Follows

1 people have added CompuMed to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, CompuMed insiders have not sold or bought any company stock.

Percentage Held by Insiders

22.00% of the stock of CompuMed is held by insiders. A high percentage of insider ownership can be a sign of company health.

CMPD Stock Analysis - Frequently Asked Questions

How have CMPD shares performed this year?

CompuMed's stock was trading at $3.81 at the start of the year. Since then, CMPD shares have decreased by 8.1% and is now trading at $3.50.
View the best growth stocks for 2025 here.

How were CompuMed's earnings last quarter?

CompuMed, Inc. (OTCMKTS:CMPD) posted its earnings results on Monday, December, 16th. The company reported $0.02 earnings per share for the quarter. CompuMed had a trailing twelve-month return on equity of 6.96% and a net margin of 3.44%.

When did CompuMed's stock split?

CompuMed's stock reverse split on Saturday, May 21st 2022. The 1-25 reverse split was announced on Saturday, May 21st 2022. The number of shares owned by shareholders was adjusted after the closing bell on Saturday, May 21st 2022. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

How do I buy shares of CompuMed?

Shares of CMPD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of CompuMed own?

Based on aggregate information from My MarketBeat watchlists, some other companies that CompuMed investors own include Yamana Gold (AUY) and Agnico Eagle Mines (AEM).

Company Calendar

• Last Earnings: 12/16/2024
• Today: 5/13/2025
• Next Earnings (Estimated): 5/13/2025
• Fiscal Year End: 9/30/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Data processing & preparation
• Sub-Industry: Business Services
• Current Symbol: OTCMKTS:CMPD
• CIK: N/A
• Web: www.compumed.net
• Phone: (310) 258-5000
• Fax: 310-645-5880
• Employees: 8
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): $0.17
• Trailing P/E Ratio: 20.59
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $190,000.00
• Net Margins: 3.44%
• Pretax Margin: 2.29%
• Return on Equity: 6.96%
• Return on Assets: 5.06%

Debt

• Debt-to-Equity Ratio: 0.05
• Current Ratio: 2.49
• Quick Ratio: 2.15

Sales & Book Value

• Annual Sales: $6.22 million
• Price / Sales: 0.75
• Cash Flow: $0.48 per share
• Price / Cash Flow: 7.24
• Book Value: $2.42 per share
• Price / Book: 1.45

Miscellaneous

• Outstanding Shares: 1,326,000
• Free Float: 1,034,000
• Market Cap: $4.64 million
• Optionable: Not Optionable
• Beta: -0.02